I8S.F INTRASENSE SAS EO -05
- Market cap
- EUR 9.44M
- P/E
- -
- P/B
- 2.03x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is I8S.F undervalued?
Graham numberThe Graham number of INTRASENSE SAS EO -05 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
INTRASENSE SAS EO -05 fundamental analysis
No fundamental analysis for INTRASENSE SAS EO -05 yet.
INTRASENSE SAS EO -05 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About INTRASENSE SAS EO -05
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was in…
Full company profileINTRASENSE SAS EO -05 financial statements
INTRASENSE SAS EO -05 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 4.19M | 3.79M | 3.31M | 2.33M | 2.99M |
| Gross Profit | 3.54M | 3.55M | 2.95M | 2.55M | 2.60M |
| Operating Income | -1.15M | -3.37M | -3.51M | -5.18M | -6.05M |
| EBITDA | - | -2.09M | -2.68M | -4.58M | -9.24M |
| Net Income | -1.20M | -3.42M | -3.58M | -5.15M | -10.8M |
| EPS | -0.04 | -0.11 | -0.07 | -0.10 | -0.21 |
| Balance Sheet | |||||
| Total Assets | 8.77M | 6.51M | 10.5M | 9.31M | 7.99M |
| Total Liabilities | 3.78M | 4.50M | 3.17M | 5.23M | 14.5M |
| Shareholders' Equity | 4.99M | 2.01M | 7.29M | 4.08M | -6.46M |
| Cash & Short-term Investments | 4.76M | 1.41M | 4.55M | 887K | 797K |
| Cash Flow | |||||
| Operating Cash Flow | -903K | -1.96M | -3.05M | -3.73M | - |
| Capital Expenditure | 554K | 1.49M | 1.93M | 2.21M | 0.00 |
| Free Cash Flow | -1.46M | -3.45M | -4.98M | -5.94M | - |
| Ratios | |||||
| ROE | -24.1% | -170.0% | -49.1% | -126.2% | - |
| ROA | -13.7% | -52.5% | -34.2% | -55.3% | -135.2% |
| Net Profit Margin | -28.7% | -90.2% | -108.3% | -220.7% | -360.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
INTRASENSE SAS EO -05 dividends
INTRASENSE SAS EO -05 has not paid dividends in the last 8 fiscal years.
Who owns INTRASENSE SAS EO -05
- Insiders 55.41%
- Institutions 0.00%
- Public & others 44.59%
- Shares outstanding 52.8M
- Free float 22.6M
INTRASENSE SAS EO -05 company profile
- Company name
- INTRASENSE SAS EO -05
- Ticker
- I8S.F
- ISIN
- FR0011179886
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 76
- Fiscal year end
- December
- Address
- 1231, avenue du Mondial 98, Montpellier, France, 34000
- Phone
- 33 4 67 13 01 30
- Website
- intrasense.fr
About INTRASENSE SAS EO -05
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrasense S.A. operates as a subsidiary of Guerbet SA.
INTRASENSE SAS EO -05 management
5- Mr. Stephen ArmandChief Executive Officer
- Pierre VoiriotChief Technical Officer
- Fanny Louvet-de VerchereChief Product & Marketing Officer
- Marion PeureuxHuman Resources Manager
- Jerome ThiebaudChief Business Officer